Skip to content

Comparison of the efficacy and safety of balloon-compression endoscopic injection sclerotherapy with transjugular intrahepatic portosystemic shunt (TIPS) in the treatment of esophageal varices

Comparison of the efficacy and safety of balloon-compression endoscopic injection sclerotherapy with transjugular intrahepatic portosystemic shunt (TIPS) in the treatment of esophageal varices

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200058926
Enrollment
Unknown
Registered
2022-04-20
Start date
2022-05-01
Completion date
Unknown
Last updated
2024-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal varices

Interventions

Group 1:balloon-compression endoscopic injection sclerotherapy
Group 2:transjugular intrahepatic portosystemic shunt (TIPS)

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-75 years; 2. The patient was diagnosed as cirrhotic with esophageal varices by medical history inquiry, laboratory examination, endoscopy, and liver color ultrasound; 3. Patients with a history of varicose bleeding and endoscopic balloon assisted sclerotherapy or transjugular portal shunt.

Exclusion criteria

Exclusion criteria: 1. Patients with bleeding in other places; 2. Patients with gastrointestinal bleeding caused by other reasons; 3. Patients with blood system diseases; 4. Patients with other severe organ complications and malignant tumors.

Design outcomes

Primary

MeasureTime frame
variceal rebleeding;mortality rate;

Secondary

MeasureTime frame
the changes of liver and renal function;

Countries

China

Contacts

Public ContactKong Derun

The First Affiliated Hospital of Anhui Medical University

kongderun168@163.com+86 13955155476

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026